Loading clinical trials...
Loading clinical trials...
Pilot Study: High Risk Breast Cancer Screening Pilot Study
Conditions
Interventions
motexafin gadolinium
biopsy
+4 more
Locations
12
United States
UCSF Cancer Center and Cancer Research Institute
San Francisco, California, United States
University of Colorado Cancer Center
Denver, Colorado, United States
Porter Adventist Hospital
Denver, Colorado, United States
Hartford Hospital
Hartford, Connecticut, United States
Lombardi Cancer Center
Washington D.C., District of Columbia, United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Start Date
June 1, 1999
Primary Completion Date
June 1, 2002
Completion Date
June 1, 2002
Last Updated
September 24, 2019
NCT05468034
NCT04541381
NCT03137095
NCT04852887
NCT07547774
NCT07040891
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions